Serum Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels Are Elevated in Acute Coronary Syndrome
Author(s) -
Kazutaka Hayashida,
Noriaki Kume,
Takatoshi Murase,
Manabu Minami,
Daisuke Nakagawa,
Tsukasa Inada,
Masaru Tanaka,
Akira Ueda,
Goro Kominami,
Hirofumi Kambara,
Takeshi Kimura,
Toru Kita
Publication year - 2005
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.104.468397
Subject(s) - medicine , acute coronary syndrome , lectin , mannan binding lectin , receptor , lipoprotein , endocrinology , immunology , cholesterol , myocardial infarction
Markers of cardiac injury, including troponin-T (TnT), are used to diagnose acute coronary syndrome (ACS); however, markers for plaque instability may be more useful for diagnosing ACS at the earliest stage. Lectin-like oxidized LDL receptor-1 (LOX-1) appears to play crucial roles in the pathogenesis of atherosclerotic plaque rupture and ACS onset. LOX-1 is released in part as soluble LOX-1 (sLOX-1) by proteolytic cleavage.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom